LBBW lifts target for Gerresheimer stock to EUR 29.00

Published on 10/27/2026 at 17:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue reached EUR 578.00 million on September 30, 2026. Gerresheimer stock costs EUR 32.83 on October 27, 2026, 0.52 percent below Xetra close.

LBBW target moves to EUR 29.00

LBBW raised its Gerresheimer target from EUR 28.00 to EUR 29.00 on October 6, 2026.
Gerresheimer reported Q2 2026 revenue of EUR 578.00 million and adjusted EBITDA of EUR 102.00 million.
Gerresheimer stock costs EUR 32.83 at Lang & Schwarz on October 27, 2026 at 5:10 p.m. CEST, 0.52 percent below the Xetra close of October 26, 2026.
The final first-half 2026 report is expected at the end of November 2026.

Gerresheimer, DE000A0LD6E6, Illustration mit AI erstellt.

Gerresheimer (ISIN DE000A0LD6E6) received a higher price target from LBBW, which lifted its target from EUR 28.00 to EUR 29.00 and kept a Hold rating on October 6, 2026, as Goldesel reported. The price stands 13.21 percent above that target. Gerresheimer was trading at EUR 32.83 at Lang & Schwarz on October 27, 2026 at 5:10 p.m. CEST, 0.52 percent below the Xetra close of October 26, 2026 at EUR 33.00.

Quarterly recovery remains uneven

Gerresheimer's preliminary second-quarter figures improved sequentially, but the year-over-year comparison remained weaker. In the report dated September 30, 2026, Gerresheimer recorded Q2 revenue of EUR 578.00 million, up EUR 55.00 million from EUR 523.00 million in the first quarter but down EUR 36.00 million from EUR 614.00 million in the prior-year quarter. Adjusted EBITDA rose from EUR 67.00 million to EUR 102.00 million, an increase of 52.24 percent, while the adjusted EBITDA margin reached 17.60 percent.

Stock stays below its yearly high

The October 27, 2026 trading range was EUR 32.32 to EUR 33.90, and the 52-week range was EUR 14.83 to EUR 34.20. At EUR 32.83, the stock stood 4.01 percent below its 52-week high. MarketScreener reported a year-to-date gain of 19.51 percent on October 27, 2026, while volume was 115,655 shares against an average of 160,549 shares.

Report date and peer valuation

Gerresheimer expects to publish its final first-half 2026 report at the end of November 2026, according to its September 30, 2026 release. The company reported first-half revenue of EUR 1.10 billion and adjusted EBITDA of EUR 168.00 million, compared with EUR 1.14 billion and EUR 224.00 million in the prior-year period.

Comparison with peers

Gerresheimer: down 0.52 percent, market capitalization EUR 1.1 billion. SCHOTT Pharma (Xetra, EUR): up 0.59 percent, P/E 28.19, market capitalization EUR 3.9 billion. Stevanato Group (Nasdaq, USD): down 1.61 percent, P/E 36.63, market capitalization USD 5.3 billion.

Target below the current quotation

LBBW's EUR 29.00 target remains below the current Lang & Schwarz quotation, despite the sequential improvement in adjusted EBITDA. The next scheduled reporting milestone is the final first-half report at the end of November 2026.

The stock was trading at EUR 32.83 at Lang & Schwarz on October 27, 2026 at 5:10 p.m. CEST, 0.52 percent below the Xetra close of October 26, 2026 at EUR 33.00. The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.